Annual Shareholders Equity
$82.89 M
-$212.07 M-71.90%
31 December 2023
Summary:
Sangamo Therapeutics annual stockholders equity is currently $82.89 million, with the most recent change of -$212.07 million (-71.90%) on 31 December 2023. During the last 3 years, it has fallen by -$415.35 million (-83.36%). SGMO annual shareholders equity is now -83.36% below its all-time high of $498.23 million, reached on 31 December 2020.SGMO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$39.13 M
+$15.44 M+65.19%
30 September 2024
Summary:
Sangamo Therapeutics quarterly stockholders equity is currently $39.13 million, with the most recent change of +$15.44 million (+65.19%) on 30 September 2024. Over the past year, it has dropped by -$95.79 million (-71.00%). SGMO quarterly shareholders equity is now -92.49% below its all-time high of $521.41 million, reached on 30 September 2020.SGMO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.9% | -71.0% |
| 3 y3 years | -83.4% | -90.4% |
| 5 y5 years | -77.4% | -90.7% |
SGMO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.4% | at low | -90.4% | +65.2% |
| 5 y | 5 years | -83.4% | at low | -92.5% | +65.2% |
| alltime | all time | -83.4% | >+9999.0% | -92.5% | +341.7% |
Sangamo Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $39.13 M(+65.2%) |
| June 2024 | - | $23.69 M(-58.2%) |
| Mar 2024 | - | $56.70 M(-31.6%) |
| Dec 2023 | $82.89 M(-71.9%) | $82.89 M(-38.6%) |
| Sept 2023 | - | $134.92 M(-42.3%) |
| June 2023 | - | $233.64 M(-30.4%) |
| Mar 2023 | - | $335.61 M(+13.8%) |
| Dec 2022 | $294.96 M(-21.4%) | $294.96 M(-4.6%) |
| Sept 2022 | - | $309.15 M(-2.9%) |
| June 2022 | - | $318.28 M(-4.9%) |
| Mar 2022 | - | $334.52 M(-10.9%) |
| Dec 2021 | $375.34 M(-24.7%) | $375.34 M(-7.6%) |
| Sept 2021 | - | $406.02 M(-8.9%) |
| June 2021 | - | $445.46 M(-5.3%) |
| Mar 2021 | - | $470.36 M(-5.6%) |
| Dec 2020 | $498.23 M(+15.2%) | $498.23 M(-4.4%) |
| Sept 2020 | - | $521.41 M(+1.9%) |
| June 2020 | - | $511.46 M(+29.7%) |
| Mar 2020 | - | $394.29 M(-8.8%) |
| Dec 2019 | $432.55 M(+18.0%) | $432.55 M(+3.2%) |
| Sept 2019 | - | $419.09 M(-5.9%) |
| June 2019 | - | $445.13 M(+35.5%) |
| Mar 2019 | - | $328.50 M(-10.4%) |
| Dec 2018 | $366.52 M(+95.1%) | $366.52 M(-3.5%) |
| Sept 2018 | - | $379.91 M(-2.1%) |
| June 2018 | - | $387.87 M(+112.7%) |
| Mar 2018 | - | $182.37 M(-2.9%) |
| Dec 2017 | $187.90 M(+38.0%) | $187.90 M(+0.7%) |
| Sept 2017 | - | $186.65 M(-3.8%) |
| June 2017 | - | $194.04 M(+54.4%) |
| Mar 2017 | - | $125.68 M(-7.7%) |
| Dec 2016 | $136.19 M(-29.2%) | $136.19 M(-5.3%) |
| Sept 2016 | - | $143.84 M(-10.1%) |
| June 2016 | - | $160.02 M(-10.8%) |
| Mar 2016 | - | $179.41 M(-6.8%) |
| Dec 2015 | $192.44 M(-6.9%) | $192.44 M(-5.5%) |
| Sept 2015 | - | $203.56 M(+1.8%) |
| June 2015 | - | $199.94 M(-3.6%) |
| Mar 2015 | - | $207.49 M(+0.4%) |
| Dec 2014 | $206.63 M(+69.8%) | $206.63 M(-1.7%) |
| Sept 2014 | - | $210.14 M(-2.0%) |
| June 2014 | - | $214.36 M(-1.4%) |
| Mar 2014 | - | $217.43 M(+78.6%) |
| Dec 2013 | $121.71 M(+87.5%) | $121.71 M(-3.5%) |
| Sept 2013 | - | $126.14 M(+112.4%) |
| June 2013 | - | $59.38 M(-3.6%) |
| Mar 2013 | - | $61.59 M(-5.1%) |
| Dec 2012 | $64.90 M(-19.0%) | $64.90 M(-2.3%) |
| Sept 2012 | - | $66.40 M(-5.4%) |
| June 2012 | - | $70.23 M(-5.5%) |
| Mar 2012 | - | $74.34 M(-7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $80.13 M(+43.3%) | $80.13 M(-4.8%) |
| Sept 2011 | - | $84.17 M(-8.1%) |
| June 2011 | - | $91.61 M(+86.4%) |
| Mar 2011 | - | $49.16 M(-12.1%) |
| Dec 2010 | $55.91 M(-22.1%) | $55.91 M(-9.3%) |
| Sept 2010 | - | $61.64 M(-10.0%) |
| June 2010 | - | $68.47 M(-2.2%) |
| Mar 2010 | - | $70.01 M(-2.5%) |
| Dec 2009 | $71.78 M(+29.6%) | $71.78 M(+61.5%) |
| Sept 2009 | - | $44.45 M(-5.8%) |
| June 2009 | - | $47.18 M(-5.6%) |
| Mar 2009 | - | $49.99 M(-9.8%) |
| Dec 2008 | $55.40 M(-23.2%) | $55.40 M(-1.1%) |
| Sept 2008 | - | $56.02 M(-7.6%) |
| June 2008 | - | $60.61 M(-8.8%) |
| Mar 2008 | - | $66.46 M(-7.9%) |
| Dec 2007 | $72.12 M(+48.1%) | $72.12 M(-4.9%) |
| Sept 2007 | - | $75.82 M(+89.9%) |
| June 2007 | - | $39.93 M(-9.1%) |
| Mar 2007 | - | $43.95 M(-9.8%) |
| Dec 2006 | $48.70 M(+28.8%) | $48.70 M(-4.4%) |
| Sept 2006 | - | $50.94 M(-4.1%) |
| June 2006 | - | $53.13 M(+49.4%) |
| Mar 2006 | - | $35.58 M(-5.9%) |
| Dec 2005 | $37.81 M(+16.8%) | $37.81 M(+68.5%) |
| Sept 2005 | - | $22.45 M(-13.4%) |
| June 2005 | - | $25.93 M(-10.7%) |
| Mar 2005 | - | $29.05 M(-10.3%) |
| Dec 2004 | $32.38 M(-27.5%) | $32.38 M(-7.4%) |
| Sept 2004 | - | $34.97 M(-11.1%) |
| June 2004 | - | $39.32 M(-7.2%) |
| Mar 2004 | - | $42.35 M(-5.2%) |
| Dec 2003 | $44.66 M(-17.7%) | $44.66 M(-2.8%) |
| Sept 2003 | - | $45.94 M(-4.9%) |
| June 2003 | - | $48.31 M(-6.1%) |
| Mar 2003 | - | $51.44 M(-5.2%) |
| Dec 2002 | $54.25 M(-34.1%) | $54.25 M(-0.6%) |
| Sept 2002 | - | $54.56 M(-27.9%) |
| June 2002 | - | $75.65 M(-3.9%) |
| Mar 2002 | - | $78.69 M(-4.4%) |
| Dec 2001 | $82.35 M(+23.1%) | $82.35 M(-2.5%) |
| Sept 2001 | - | $84.43 M(+31.2%) |
| June 2001 | - | $64.37 M(-2.3%) |
| Mar 2001 | - | $65.86 M(-1.5%) |
| Dec 2000 | $66.89 M(+746.7%) | $66.89 M(-1.8%) |
| Sept 2000 | - | $68.14 M(-0.8%) |
| June 2000 | - | $68.72 M(+675.6%) |
| Mar 2000 | - | $8.86 M |
| Dec 1999 | $7.90 M(+132.1%) | - |
| Dec 1998 | $3.40 M(-46.9%) | - |
| Dec 1997 | $6.41 M(+1376.7%) | - |
| Dec 1996 | $434.00 K | - |
FAQ
- What is Sangamo Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual shareholders equity year-on-year change?
- What is Sangamo Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly shareholders equity year-on-year change?
What is Sangamo Therapeutics annual stockholders equity?
The current annual shareholders equity of SGMO is $82.89 M
What is the all time high annual shareholders equity for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual stockholders equity is $498.23 M
What is Sangamo Therapeutics annual shareholders equity year-on-year change?
Over the past year, SGMO annual stockholders equity has changed by -$212.07 M (-71.90%)
What is Sangamo Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SGMO is $39.13 M
What is the all time high quarterly shareholders equity for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly stockholders equity is $521.41 M
What is Sangamo Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SGMO quarterly stockholders equity has changed by -$95.79 M (-71.00%)